Clinical evaluation of AYUSH PE eye drops in the management of Acute AllergicConjunctivitis

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1. Patients of either sex aged between 18-60 years
•2. Patients presenting with signs and symptoms of Acute Allergic Conjunctivitis like Itching, Redness, Watering, Swelling and Foreign body sensation as assessed through Visual Analogue Scale (VAS) Scoring Method
•3. Patients with presence of Papillae in conjunctiva on examination through Slit Lamp Examination (SLE) and/ or positive conjunctival smear test for Acute Allergic Conjunctivitis (presence of abundance of eosinophils).
•4. Willing and able to participate for 2 weeks.

•1.Patients having other form than SAC, PAC of Allergic Conjunctivitis - like Vernal Kerato-conjunctivitis, Atopic Kerato-
•conjunctivitis, Giant Papillary Conjunctivitis, Phlyctenular conjunctivitis etc.
•2.Patients having any other associated ocular pathology like marginal Corneal ulcer, Dacryocystitis, Trachoma, Kerato-Conjunctivitis,infective Conjunctivitis etc clinically.
•3.Patients with concurrent serious hepatic disorder, renal disorder, Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and
•/ or Chronic Obstructive Pulmonary Disease (COPD) or uncontrolled metabolic diseases (Diabetes Mellitus, Hypertension etc) or any evidenceof malignancy.
•4.Pregnant / lactating females.
•5.Patients on steroids, oral contraceptives, or estrogen replacement
•6.Smokers/Alcoholics and/or drug abusers.
•7.H/o Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro- Endocrinal disorders, etc..
•8.H/o hypersensitivity to the trial drug or any of its ingredients.
•9.Patients who have completed participation in any other clinical trial during the past six months.
•10.Any other condition which the Investigator
•thinks may jeopardize the study.

发起方